Metagenomi, Inc. financial data

Industry
Biological Products, (No Diagnostic Substances)
Location
5959 Horton Street, 7 Th Floor, Emeryville, California
Fiscal year end
December 31
Former names
Metagenomi Technologies, LLC (to 1/18/2024)
Latest financial report
Q1 2024 - May 14, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.5 M shares
Common Stock, Shares, Outstanding 37.5 M shares
Common Stock, Value, Issued 4 K USD
Weighted Average Number of Shares Outstanding, Basic 21.1 M shares +521%
Weighted Average Number of Shares Outstanding, Diluted 21.1 M shares +521%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 11.2 M USD +28.9%
Research and Development Expense 31.4 M USD +56.2%
General and Administrative Expense 8.75 M USD +35.4%
Operating Income (Loss) -29 M USD -61.8%
Nonoperating Income (Expense) 3.88 M USD -2.95%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -25.1 M USD -80.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -25.1 M USD -55.9%
Earnings Per Share, Basic -1.19 USD/shares +74.9%
Earnings Per Share, Diluted -1.19 USD/shares +74.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 103 M USD +7.2%
Cash, Cash Equivalents, and Short-term Investments 327 M USD
Assets, Current 336 M USD
Property, Plant and Equipment, Net 21 M USD
Operating Lease, Right-of-Use Asset 42.5 M USD
Other Assets, Noncurrent 379 K USD
Assets 415 M USD
Accounts Payable, Current 6.84 M USD
Contract with Customer, Liability, Current 48.3 M USD
Liabilities, Current 70.7 M USD
Contract with Customer, Liability, Noncurrent 20.3 M USD
Operating Lease, Liability, Noncurrent 43.7 M USD
Other Liabilities, Noncurrent 5.08 M USD
Liabilities 140 M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -278 K USD
Retained Earnings (Accumulated Deficit) -170 M USD
Stockholders' Equity Attributable to Parent 276 M USD
Liabilities and Equity 415 M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.9 M USD -42.2%
Net Cash Provided by (Used in) Financing Activities 86.5 M USD +1915%
Net Cash Provided by (Used in) Investing Activities -94.7 M USD -31.4%
Common Stock, Shares Authorized 500 M shares
Common Stock, Shares, Issued 37.5 M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -38 M USD +57.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 108 M USD +5.96%
Depreciation 1.27 M USD +51.4%
Payments to Acquire Property, Plant, and Equipment 915 K USD -65.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -25.3 M USD -57.2%
Operating Lease, Liability, Current 4.38 M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares
Additional Paid in Capital 446 M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 5.06 M USD +856%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares